Kristian Borbos
Fortuna: 152 729 $ al 30/06/2026
Fortuna: 152 729 $ al 30/06/2026
Kristian Borbos is currently Deputy Director at Ascelia Incentive AB and Chief Financial Officer at Gubra A since 2022.
Former roles include Chief Financial Officer at Ascelia Pharma AB from 2017 to 2022, Manager-Business Finance at Novozymes A from 2016 to 2017, and Lead Manager-Investor Relations at Ørsted A and Ørsted AB from 2009 to 2016.
Education includes graduate studies at the University of Lund.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GUBRA A/S 0,02 % | 31/12/2025 | 3.103 ( 0,02 % ) | 152 729 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GUBRA A/S | Director Financiero/CFO | 01/08/2022 |
Ascelia Incentive AB | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ASCELIA PHARMA AB | Director Financiero/CFO | 01/09/2022 |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Corporate Officer/Principal | 01/09/2017 |
| ORSTED A/S | Public Communications Contact | 01/07/2016 |
Ørsted AB
Ørsted AB Gas DistributorsUtilities Produces and distributes natural gas and oil products | Contacto de Relaciones con Inversores | 01/07/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Ørsted A/S
Ørsted A/S Electric UtilitiesUtilities Develops, constructs and operates offshore and onshore wind farms, solar farms, energy storage facilities, renewable hydrogen and green fuels facilities and bioenergy plants | Utilities |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ørsted AB
Ørsted AB Gas DistributorsUtilities Produces and distributes natural gas and oil products | Utilities |
Ascelia Pharma AB
Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Gubra A/S
Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company | Commercial Services |
Ascelia Incentive AB |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.